P. Wang

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

N. Ratner, T. Rizvi, T. Cripe, 2017, Oncotarget.

Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy.

A. Barski, F. Finkelman, K. Izuhara, 2015, Immunity.

VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.

L. Boon, David A Hildeman, A. Sholl, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children

J. Markert, E. Beierle, T. Cripe, 2015, Molecular therapy oncolytics.

The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.

A. Bottaro, C. Jordan, T. Bushnell, 2008, Blood.

Gene Editing Thumbs a Ride with Oncolytic Virotherapy.

T. Cripe, P. Wang, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Neuroblastomas Vary Widely in Their Sensitivities to Herpes Simplex Virotherapy Unrelated to Virus Receptors and Susceptibility

P. Grandi, J. Glorioso, T. Cripe, 2015, Gene Therapy.

Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics

E. Mardis, V. Magrini, J. Mendell, 2022, Science advances.

High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

C. Jordan, C. Mullen, F. Young, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles

Xiaoliu Zhang, T. Cripe, Xinping Fu, 2018, Oncotarget.

Alternative RNA Splicing Defects in Pediatric Cancers: New Insights in Tumorigenesis and Potential Therapeutic Vulnerabilities.

D. Chandler, T. Cripe, E. Mardis, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.